The Prostate Cancer Foundation (PCF): CF TACTICAL Award (Therapy ACceleration To Intercept CAncer Lethality)- LOI

qualified teams of investigators from academic and community institutions that will directly contribute to improved outcomes for patients with prostate cancer with lethal potential. These awards will be funded depending on the level of innovation and transformative potential in applications received. PCF seeks high-risk, currently unfunded projects from academic and community research institutions around the world. TACTICAL Awards provide $5 – $10 Million U.S.D. per award over 3–5 years. (No overhead)

https://www.pcf.org/our-work/open-rfas-rfps/

https://res.cloudinary.com/pcf/images/v1768591135/2026-TACTICAL-Award-RFA_FINAL/2026-TACTICAL-Award-RFA_FINAL.pdf?_i=AA